Corvus Pharmaceuticals, Inc. (CRVS)
13.33
-0.76
(-5.39%)
USD |
NASDAQ |
Mar 20, 16:00
13.59
+0.26
(+1.95%)
After-Hours: 20:00
Corvus Pharmaceuticals Research and Development Expense (Quarterly) : 9.939M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Plus Therapeutics, Inc. | 2.941M |
| Geron Corp. | 15.83M |
| Nektar Therapeutics | 29.68M |
| Jaguar Health, Inc. | 3.658M |